Forbes December 22, 2024
Bruce Japsen

Legislation slowly wending its way through states and in Washington could mean increased payments to drugstore chains like CVS Health, Walgreens, Walmart and independent pharmacies across the country.

Though pharmacies didn’t get what they wanted last week from Congress in a year-end spending package, the door has been opened wider to legislation to benefit pharmacies while regulating pharmacy benefit managers, or PBMs, even with Republicans in control of both houses of Congress and the White House in 2025.

“PBM reform is supported by majorities in both parties, by outgoing President Biden, and by incoming President-elect Trump,” said B. Douglas Hoey, the chief executive of the National Community Pharmacists Association after Congress late last week passed a new short-term spending package...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Why Walgreens Is Reportedly Considering a Private Equity Buyer
PBM reform dropped in Congress' funding package
2025 and Beyond: Key Trends to Watch in Pharmacy
U.S. Health Care Spending Reaches $4.9 Trillion
Mark Cuban: A Master Disrupter for American Healthcare

Share This Article